8-K 1 e19509_8k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2004 MOLECULAR DEVICES CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0-27316 94-2914362 (Commission File Number) (IRS Employer Identification No.) 1311 Orleans Drive Sunnyvale, CA 94089 (Address of Principal Executive Offices, including Zip Code) Registrant's telephone number, including area code: (408) 747-1700 ----------------- -------------------------------------------------------------------------------- Item 2.02. Results of Operations and Financial Condition. On October 28, 2004, Molecular Devices Corporation ("Molecular Devices") reported its financial results for the quarter ended September 30, 2004. A copy of the press release issued by Molecular Devices on October 28, 2004 concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Molecular Devices, whether made before or after the date hereof, regardless of any general incorporation language in such filing. Item 9.01. Financial Statements and Exhibits (c) Exhibit 99.1 Press release dated October 28, 2004, entitled "Molecular Devices Reports Record Revenues and Earnings for Third Quarter of 2004", issued by Molecular Devices. -------------------------------------------------------------------------------- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOLECULAR DEVICES CORPORATION Dated: October 28, 2004 By: /s/ Timothy A. Harkness ------------------------------- Timothy A. Harkness Senior Vice President and Chief Financial Officer -------------------------------------------------------------------------------- Exhibit 99.1 Press release dated October 28, 2004, entitled "Molecular Devices Reports Record Revenues and Earnings for Third Quarter of 2004", issued by Molecular Devices.